Everett Harris & Co /Ca/ / ABBV
Everett Harris & Co /Ca/’s Abbvie Inc Position
Does Everett Harris & Co /Ca/ own Abbvie Inc (ABBV)? Yes — 513.4K shares worth $112M (+1.44% of its 13F portfolio) as of Q1 2026, down from 517.0K shares the prior filed quarter.
Position Value
$112M
Q1 2026
Shares
513.4K
% of Portfolio
+1.44%
Quarters Held
30
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 513.4K | $112M | +1.44% |
| Q4 2025 | 517.0K | $118M | +1.43% |
| Q3 2025 | 517.8K | $120M | +1.48% |
| Q2 2025 | 521.3K | $97M | +1.24% |
| Q1 2025 | 524.1K | $110M | +1.41% |
| Q4 2024 | 528.1K | $94M | +1.18% |
| Q3 2024 | 528.9K | $104M | +1.30% |
| Q2 2024 | 531.2K | $91M | +1.17% |
| Q1 2024 | 533.7K | $97M | +1.29% |
| Q4 2023 | 537.1K | $83M | +1.19% |
| Q3 2023 | 541.0K | $81M | +1.26% |
| Q2 2023 | 545.6K | $74M | +1.12% |
| Q1 2023 | 552.3K | $88M | +1.43% |
| Q4 2022 | 553.3K | $89M | +1.54% |
| Q3 2022 | 555.4K | $75M | +1.37% |
| Q2 2022 | 554.2K | $85M | +1.47% |
| Q1 2022 | 560.6K | $91M | +1.29% |
| Q4 2021 | 559.0K | $76M | +1.05% |
| Q3 2021 | 513.9K | $55M | +0.88% |
| Q2 2021 | 497.4K | $56M | +0.90% |
| Q1 2021 | 474.5K | $51M | +0.89% |
| Q4 2020 | 404.5K | $43M | +0.77% |
| Q3 2020 | 365.5K | $32M | +0.63% |
| Q2 2020 | 365.4K | $36M | +0.79% |
| Q1 2020 | 364.5K | $28M | +0.72% |
| Q4 2019 | 354.5K | $31M | +0.71% |
| Q3 2019 | 355.5K | $27M | +0.67% |
| Q2 2019 | 366.5K | $27M | +0.67% |
| Q1 2019 | 360.5K | $29M | +0.75% |
| Q4 2018 | 362.5K | $33M | +0.95% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Everett Harris & Co /Ca/’s full portfolio or all institutional holders of ABBV.